School of Allied Health, La Trobe University, Melbourne, Victoria, Australia
Graduate School of Health, University of Technology, Sydney, New South Wales, Australia.
Br J Sports Med. 2022 Aug;56(15):877-887. doi: 10.1136/bjsports-2021-104548. Epub 2022 Apr 8.
Evaluate properties of outcome measures for gluteal tendinopathy.
Multistage scoping/systematic review.
Cochrane, PubMed, Embase, Scopus, Web of Science, PEDro, CINAHL, SPORTDISCUS were searched (December 2021) to identify measures used to evaluate gluteal tendinopathy. Measures were mapped to the core health domains for tendinopathy. Medline, CINAHL, Embase and PubMed were searched (December 2021) for studies evaluating measurement properties of gluteal tendinopathy outcome measures captured in the initial search. Both reviews included studies that evaluated a treatment in participants with gluteal tendinopathy, diagnosed by a professional. Consensus-based-Standards for the Selection of Health Instruments methodology were followed-including bias assessment and synthesis of findings.
Six studies reported on the Victorian Institute of Sport Assessment-Gluteal Tendinopathy (VISA-G). One study reported on the Hip Outcome Score (HOS)-activities of daily living (ADL) and Sport.The VISA-G had moderate-quality evidence of sufficient construct validity (known group) and responsiveness (pre-post intervention), low-quality evidence of sufficient reliability, measurement error, comprehensibility and insufficient construct validity (convergent), and very low-quality evidence of sufficient comprehensiveness, relevance and responsiveness (comparison with other outcome measures).Both the HOS(ADL) and HOS(Sport) had very low-quality evidence of sufficient reliability, relevance and insufficient construct validity and comprehensiveness. The HOS(ADL) had very low-quality evidence of sufficient comprehensibility and insufficient measurement error. The HOS(Sport) had very low quality evidence of inconsistent comprehensibility and sufficient measurement error.
Rigorously validated outcome measures for gluteal tendinopathy are lacking. The VISA-G is the preferred available option to capture the disability associated with gluteal tendinopathy.
评估臀肌腱病结局测量指标的特性。
多阶段范围界定/系统评价。
Cochrane、PubMed、Embase、Scopus、Web of Science、PEDro、CINAHL、SPORTDISCUS 于 2021 年 12 月进行检索，以确定用于评估臀肌腱病的测量指标。这些指标与肌腱病的核心健康领域相映射。Medline、CINAHL、Embase 和 PubMed 于 2021 年 12 月进行检索，以确定评估初始检索中捕获的臀肌腱病结局测量指标的测量特性的研究。这两项研究均纳入了由专业人员诊断为臀肌腱病的参与者接受治疗的研究。采用基于共识的健康工具选择标准（COSMIN）方法，包括偏倚评估和结果综合。
有 6 项研究报告了维多利亚运动研究所-臀肌腱病评估量表（VISA-G）的情况。有 1 项研究报告了髋关节评分（HOS）-日常生活活动（ADL）和运动情况。VISA-G 在结构效度（已知组）和反应度（干预前后）方面具有中等质量证据，在可靠性、测量误差、理解性和结构效度（聚合）方面具有低质量证据，在充分的全面性、相关性和反应度（与其他结局测量指标比较）方面具有非常低质量证据。HOS（ADL）和 HOS（运动）在可靠性、相关性和结构效度及全面性方面均具有非常低质量证据。HOS（ADL）在理解性和测量误差方面具有非常低质量证据，在全面性方面具有低质量证据。HOS（运动）在理解性方面具有不一致的全面性和充分的测量误差。
缺乏针对臀肌腱病的经过严格验证的结局测量指标。VISA-G 是评估臀肌腱病相关残疾的首选指标。
